Skip to main content

3 Result(s)

within A. Vigani Remove this filter English Remove this filter

and

  1. No Access

    Chapter and Conference Paper

    Double 5-FU modulation with folinic acid and recombinant alfa2b-Interferon : a phase I–II study in metastatic colorectal cancer patients

    5-Fluorouracil (5-FU) is the most widely employed chemotherapeutic agent for patients with metastatic colorectal cancer (MCC) and objective response rates (ORR) are achievable in approximately 10–20 Wo of trea...

    I. Brunetti, A. Falcone, A. Vigani… in Proceedings of the 3rd International Congr… (1991)

  2. No Access

    Article

    A feasibility study of accelerated polychemotherapy with cisplatin, epidoxorubicin and cyclophosphamide (PEC) in advanced ovarian cancer

    We have evaluated the feasibility of an increase in dose intensity of the cisplatin, epidoxorubicin and cyclophosphamide (PEC) regimen, with granulocyte colony-stimulating factor (G-CSF) support, in 22 patient...

    P Pronzato, G Bertelli, A Vigani, F Vaira in British Journal of Cancer (1996)

  3. No Access

    Article

    Phase II study of vinorelbine and ifosfamide in anthtracycline resistent metastatic breast cancer

    The new combination of ifosfamide and vinorelbine wasevaluated in a phase II study of patientswith metastatic breast cancer. All the patients hadevaluable or measurable lesions resistant to the combinationof c...

    P. Pronzato, P. Queirolo, M. Landucci, F. Vaira… in Breast Cancer Research and Treatment (1997)